1. Evaluation
of the Med Safety mobile app for reporting adverse events in Burkina Faso—shows
increased reporting after implementing mobile-based ADR tools. SpringerLink
2. Smartphone-based
mobile applications for adverse drug reactions reporting: global status and
country experience – impact and lessons of ADR apps globally. SpringerLink
3.
Effectiveness of mobile applications
in enhancing adverse drug reaction reporting: a systematic review –
compares reporting rates, completeness, and user engagement. BioMed
Central
4. Drug-drug interactions and adverse drug
reactions in polypharmacy among older adults: an integrative review. PubMed
5. A meta-analysis assessing the prevalence of
drug-drug interactions among hospitalized patients. PubMed
6. Prevalence of drug–drug interactions in
geriatric patients at an ambulatory care pharmacy in a tertiary care teaching
hospital. BioMed
Central
7. Drug-drug interactions among hospitalized
elderly patients in Northwest Ethiopia: observational study. SAGE
Journals
8. A study on drug-drug interactions through
prescription analysis in a South Indian teaching hospital. PubMed
9. Prevalence of potential drug-drug
interactions and associated factors among outpatients and inpatients in
Ethiopian hospitals: systematic review & meta-analysis. PubMed
10. Drug-drug interaction among elderly patients
in Africa: systematic review and meta-analysis. BioMed
Central
11. The prevalence and severity of potential
drug-drug interactions among adult polypharmacy patients at outpatient clinics
in Jordan. PMC
12. Drug information-seeking behaviours of
physicians, nurses and pharmacists: systematic review. PubMed
13. Harnessing scientific literature reports for
pharmacovigilance: prototype tool development & usability testing. PubMed
14. Modeling polypharmacy side effects with graph
convolutional networks. arXiv
15. Predicting rich drug-drug interactions via
biomedical knowledge graphs. arXiv
16. CASTER: Predicting drug interactions with
chemical substructure representation. arXiv
17. Assessment of drug-drug interactions in the
prescription of elderly patients on cardiovascular drugs. IJBC
Pharmacology+1
18. Clinical assessment and management of
drug-drug interactions in hypertensive patients with comorbidities. jpbs.in+1
19. Next.js
— Architecture & Docs. Next.js
20. Next.js
— Server-Side Rendering documentation. Next.js
21. Next.js
— Building APIs with Next.js (blog). Next.js
22. Strapi
blog — SSR vs SSG in Next.js (guidance on rendering strategies). Strapi
23. Tailwind
CSS — benefits and real-world usage (Grid Dynamics blog). Grid
Dynamics
24. IJRPR
— Tailwind CSS research article (utility-first evaluation). IJRPR
25. shadcn/ui
— docs & Next.js integration. Shadcn UI+1
26. Lucide
/ lucide-react (icon library docs). Lucide+1
27. MDN
— Using Mongoose with Node.js (tutorial). MDN Web
Docs
28. Mongoose
ODM — best practices and patterns (dev.to / Medium articles). DEV
Community+1
29. MongoDB
— healthcare & AI use cases (MongoDB blog). MongoDB
30. Performance
analysis / benchmarking of NoSQL DBs for healthcare (research article). ResearchGate
31. Clean
architecture patterns with Node.js, Mongoose & MongoDB (tutorial). Medium
32. MERN
Stack review (impact and practical considerations). ijgst.com
33. Practical
guide: API Routes & patterns in Next.js (community tutorial). Medium
34. Hammar, T. et al. (2021). Current
Knowledge about Providing Drug–Drug Interaction Information through Mobile
Applications. PubMed Central. PMC
35. Fukushima, A. et al. (2022). Smartphone-based
mobile applications for adverse drug reaction reporting: A systematic review.
PubMed Central. PMC
36. Hyzy, M. et al. (2022). System Usability
Scale Benchmarking for Digital Health Apps. JMIR mHealth and uHealth. JMIR
mHealth and uHealth
37. Parracha, E. R. et al. (2022). Mobile apps
for quick adverse drug reaction report. PubMed Central. PMC
38. Hyzy, M. et al. (2022). System Usability
Scale Benchmarking for Digital Health Apps. PubMed Central. PMC
39. Dedefo, M. G. (2025). Completeness of
spontaneously reported adverse drug reactions: A comparative study. Wiley
Online Library. BPS
Publications
40. Leskur, D. (2022). Adverse drug reaction
reporting via mobile applications. ScienceDirect. ScienceDirect
41. Dubale, A. T. et al. (2024). Healthcare
professionals' willingness to utilize a mobile health application for ADR
reporting. ScienceDirect. ScienceDirect
42. Kim, B. Y. B. et al. (2018). Consumer
Mobile Apps for Potential Drug-Drug Interaction Checking: A Systematic Review.
PubMed Central. PMC
43. Parracha, E. R. et al. (2023). Mobile apps
for quick adverse drug reaction report: A systematic review. Wiley Online
Library. Wiley
Online Library
44. Wells, C. (2022). An Overview of
Smartphone Apps in Healthcare. National Center for Biotechnology
Information. NCBI
45. Busari, A. (2024). Assessing the Impact of
Usability from Evaluating Mobile Health Applications. Skeena Publishers. Skeena
Publishers | Open Access Journals
46. Zhou, L. et al. (2019). The mHealth App
Usability Questionnaire (MAUQ): Development and Validation. JMIR mHealth
and uHealth. JMIR
mHealth and uHealth
47. García-Sánchez, S. et al. (2022). Mobile
Health Apps Providing Information on Drugs for Adult Emergency Professionals.
JMIR mHealth and uHealth. JMIR
mHealth and uHealth
48. Domián, B. M. et al. (2025). Comparative
evaluation of artificial intelligence platforms for drug interaction prediction.
ScienceDirect. ScienceDirect
49. Leskur, D. (2022). Adverse drug reaction
reporting via mobile applications. ScienceDirect. ScienceDirect
50. Parracha, E. R. et al. (2022). Mobile apps
for quick adverse drug reaction report. PubMed Central. PMC
51. Hyzy, M. et al. (2022). System Usability
Scale Benchmarking for Digital Health Apps. PubMed Central. PMC
52. Dedefo, M. G. (2025). Completeness of
spontaneously reported adverse drug reactions: A comparative study. Wiley
Online Library. BPS
Publications
53. Hyzy, M. et al. (2022). System Usability
Scale Benchmarking for Digital Health Apps. PubMed Central. JMIR
mHealth and uHealth
54. Current Knowledge about Providing Drug–Drug
Interaction Services (scoping review) — discusses challenges, accuracy,
coverage of DDI tools. PMC
55. Content and Usability Evaluation of Patient
Oriented Drug-Drug Interaction Website — evaluates correctness and usability of
DDI tools. PMC
56. Effectiveness of Mobile Applications in
Enhancing Adverse Drug Reaction Reporting — compares ADR report quality via
apps vs traditional methods. BioMed
Central
57. Evaluation of the Med Safety Mobile App for
Reporting Adverse Events in Burkina Faso — a real implementation and evaluation
of ADR reporting via app. SpringerLink
58. Design and Development of a Mobile
Application for Medication Information (Agudelo et al., 2025) — example of
similar app with information modules. ScienceDirect
59. Application of Artificial Intelligence in
Drug–Drug Interactions — review of predictive models and data sources used for
DDI prediction. ACS
Publications
60. Artificial Intelligence-Driven Drug
Interaction Prediction — discusses ML/AI approaches for interaction
sensitivity/specificity. ResearchGate
61. Factors Influencing the Use of a Mobile App
for ADR Reporting — qualitative study on adoption, usability,
barriers/facilitators. PubMed
62. Adverse Drug Reaction Reporting via Mobile
Applications: A Narrative Review — summary of ADR apps, advantages,
limitations. ResearchGate
63. A Web-Based Tool to Report Adverse Drug
Reactions — usability evaluation of web ADR reporting systems. Formative
64. A Mobile App Leveraging Citizen Engagement for
ADR Reporting — describes usability and features related to ADR apps. Human
Factors
65. Regulators Move Toward ADR Reporting via
Mobile Apps — overview of policy trends and adoption in pharmacovigilance. ResearchGate
66. Qualitative Study Using Task-Technology Fit
Framework for ADR Reporting by Community Pharmacists — barriers/facilitators
and design needs. I-JMR
67. Consumer Views on the Use of Digital Tools for
Reporting ADRs — analysis of uptake, user experience, reporting changes. PMC
68. Evaluation of the Performance of DDI Screening
Software in Pharmacies — a benchmark study of DDI detection in pharmacy
systems. ResearchGate